KalVista Pharmaceuticals
KALV
KALV
93 hedge funds and large institutions have $459M invested in KalVista Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 22 reducing their positions, and 22 closing their positions.
Holders
93
Holders Change
-8
Holders Change %
-7.92%
% of All Funds
1.36%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
14
Increased
46
Reduced
22
Closed
22
Calls
$21.3M
Puts
$11.3M
Net Calls
+$10.1M
Net Calls Change
+$3.39M
Top Buyers
1 |
VA
1
VR Adviser
New York
|
$50.1M |
2 |
2
Morgan Stanley
New York
|
$11.1M |
3 |
3
BlackRock
New York
|
$27.5M |
4 |
SC
4
Stempoint Capital
New York
|
$5.18M |
5 |
FLSM
5
Frazier Life Sciences Management
Palo Alto,
California
|
$44.4M |